Kontafarma China Holdings Limited (HKG:1312)
Hong Kong · Delayed Price · Currency is HKD 0.0330
0.00 (0.00%)
Oct 9, 2026, 3:59 PM HKT
Kontafarma China Holdings Market Cap
Kontafarma China Holdings has a market cap or net worth of 184.42 million as of October 9, 2026. It is the 35,996th most valuable company in the world and the 1,968th biggest in Hong Kong. Its market cap has decreased by 2.94% in one year.
Market Cap
184.42M
Enterprise Value
214.65M
Revenue
845.33M
Global Rank
Country Rank
#1,968 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2012, Kontafarma China Holdings's market cap has decreased from 719.40M to 184.42M, a decrease of -74.36%. That is a compound annual growth rate of -8.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 184.42M | 13.79% |
| Dec 31, 2025 | 162.07M | 11.54% |
| Dec 31, 2024 | 145.30M | -27.78% |
| Dec 29, 2023 | 201.19M | -20.00% |
| Dec 30, 2022 | 251.49M | -8.16% |
| Dec 31, 2021 | 273.84M | -43.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pak Fah Yeow International | 744.82M |
| Lee's Pharmaceutical Holdings | 677.16M |
| Zhongzhi Pharmaceutical Holdings | 634.75M |
| Wai Yuen Tong Medicine Holdings | 423.47M |
| Tianda Pharmaceuticals | 260.16M |
| Regent Pacific Group | 255.34M |
| Extrawell Pharmaceutical Holdings | 223.30M |
| Shenzhen Neptunus Interlong Bio-technique Company | 154.38M |